Multidose transdermal drug delivery system

Details Multidose transdermal drug delivery system Multidose transdermal drug delivery system

1992-08-10

1998-05-26

Phelan, D. Gabrielle

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Web, sheet or filament bases; compositions of bandages; or...

424448, 602 41, 602 43, 602 52, 602 54, 602 57, A61F 1300

Patent

active

057561176

ABSTRACT:
A multidose transdermal drug delivery system comprises a laminate composite with a plurality of compartments. Each compartment is a reservoir for a unit dose of a drug active to be transdermally administered. The assembly is adhesively secured to the skin of a patient. Individual seals are provided for resealably enclosing the drug active in each of the reservoirs. The individual enclosing seals are removable to release the unit dose into contact with the skin of the patient and are actuable to control the transdermal absorption of the drug actives. Provisions are also made to automatically indicate the activation of the drug and to prevent an accidental release of medicament.

REFERENCES:
patent: 3161602 (1964-12-01), Herbig et al.
patent: 3270100 (1966-08-01), Jolkouski et al.
patent: 3336155 (1967-08-01), Rowe
patent: 3341466 (1967-09-01), Brynko et al.
patent: 3396117 (1968-08-01), Schatze
patent: 3405070 (1968-10-01), Zolla
patent: 3567650 (1971-03-01), Bakan
patent: 3797494 (1974-03-01), Zattaroni
patent: 3875074 (1975-04-01), Vassiliades et al.
patent: 4145184 (1979-03-01), Brain et al.
patent: 4207315 (1980-06-01), Voorhees
patent: 4277364 (1981-07-01), Shasha et al.
patent: 4391909 (1983-07-01), Lim
patent: 4422970 (1983-12-01), Rajadhyaksha
patent: 4460368 (1984-07-01), Allison
patent: 4666441 (1987-05-01), Androla et al.
patent: 4708716 (1987-11-01), Sibalis
patent: 4743249 (1988-05-01), Loveland
patent: 4806355 (1989-02-01), Goosen et al.
patent: 4834978 (1989-05-01), Nuwayset
patent: 4904475 (1990-02-01), Gale
patent: 4913905 (1990-04-01), Fankhauser et al.
patent: 4917676 (1990-04-01), Heiber et al.
patent: 4917688 (1990-04-01), Nelson
patent: 5028435 (1991-07-01), Katz et al.
patent: 5032403 (1991-07-01), Sinnteich
patent: 5042975 (1991-08-01), Chien et al.
patent: 5064422 (1991-11-01), Wick
patent: 5064654 (1991-11-01), Berner et al.
patent: 5071704 (1991-12-01), Fischel-Ghodsian
"Aminoguanidine, a Novel Inhibitor of Nitric Oxide Formation, Prevents Diabetic Vascular Dysfunction" Corbett et al, Diabetes, vol. 7, Apr. 1992, pp. 552-556.
Effect of Aminoguanidine on Functional and Structural Abnormalities in Peripheral Neive of STZ-Induced Diabetic Rates Yagihashi et al, Diabetes, vol. 41, Jan. 1992, pp. 47-52.
"Transdermal Delivery of Drugs" R. Vaidyanathan et al, vol. 2, pp. 63-83, 1990.
"Wirkung Peroraler und Transdermaler Insulin-Praparationen auf Blutglukose--Konzentiationen bei Mausen" Biedtke et al., Arnzeim.-Forsch./Drug Res. 40, No. 8 1990 pp. 880-883.
Transdermale Applikation vor Insulin ber TypII-Dia-Betiken, Liedtke et al., Drug Res. 40, No. 8, 1990, pp. 884-887.
Mechanistic Studies of Advanced Glycosylation End Product Inhibition by Aminoguanidine Diane Edelstein et al., Diabetes, vol. 41, Jan. 1992, pp. 26-29.
Retardation by Aminoguanidine of Development of Albuminura, Mesangial Expansion, and Tissue Fluorescene in Streptozocin--Induced Diabetic Rat, Soulis-Liparofa et al, Diabetes, vol. 40, Oct. 1991, pp. 1328-1334.

Affiliated with

Also associated with

Rating

Multidose transdermal drug delivery system does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Multidose transdermal drug delivery system, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Multidose transdermal drug delivery system will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1957439